Abbott settles Texas AWP suit
Abbott agreed to pay the state of Texas approximately $18 million in damages and $10 million in attorney's fees and costs to settle claims it inflated the average wholesale price of prescription drugs purchased by the state's Medicaid program. The Texas Attorney General has reached similar settlements with several other companies, including a $27 million settlement with Schering and Warrick in 2004 and a $10 million deal with Boehringer Ingelheim and Roxane Labs in 2005. Additional actions are pending against several other companies, including Barr and Watson
You may also be interested in...
Can a false-claims suit be filed if doctors have different opinions about whether a treatment was necessary? The Supreme Court won’t say.
No device-related close-out letters were released by the US FDA last month.
The pharmaceutical industry and other stakeholders have taken part in the launch event for a new initiative intended to tackle issues that have been amplified by the COVID-19 pandemic, such as supply chain resilience and medicine shortages. The project has drawn a mixed response from industry bodies.